Ovid Therapeutics Inc. Intellectual Property Contracts & Agreements

8 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement between AstraZeneca AB and Ovid Therapeutics Inc. (December 30, 2021)
License Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2022
Royalty, License and Termination Agreement between Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc. (March 2, 2021)
License Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2021
Collaboration and License Agreement between Ovid Therapeutics Inc. and Angelini Pharma Rare Diseases AG (July 8, 2020)
License Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2020
First Amendment to License Agreement between Ovid Therapeutics Inc. and H. Lundbeck A/S (May 10, 2019)
License Agreements
Ovid Therapeutics Inc.
Biotechnology
2019
License Agreement between Northwestern University and Ovid Therapeutics (December 15, 2016)
License Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2018
License Agreement between H. Lundbeck A/S and Ovid Therapeutics Inc. for Gaboxadol Development and Commercialization
License Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
License and Collaboration Agreement between Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc.
License Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
License Agreement between H. Lundbeck A/S and Ovid Therapeutics Inc. for Gaboxadol Development and Commercialization
License Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017